RU2002129354A - Ethylenediamine derivatives - Google Patents
Ethylenediamine derivativesInfo
- Publication number
- RU2002129354A RU2002129354A RU2002129354/04A RU2002129354A RU2002129354A RU 2002129354 A RU2002129354 A RU 2002129354A RU 2002129354/04 A RU2002129354/04 A RU 2002129354/04A RU 2002129354 A RU2002129354 A RU 2002129354A RU 2002129354 A RU2002129354 A RU 2002129354A
- Authority
- RU
- Russia
- Prior art keywords
- group
- substituted
- alkyl
- salt
- saturated
- Prior art date
Links
Claims (21)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000-108047 | 2000-04-05 | ||
| JP2000108047 | 2000-04-05 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2002129354A true RU2002129354A (en) | 2004-05-10 |
| RU2268259C2 RU2268259C2 (en) | 2006-01-20 |
Family
ID=18620961
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2002129354/04A RU2268259C2 (en) | 2000-04-05 | 2001-04-05 | ETHYLENEDIAMINE DERIVATIVES AND FXa INHIBITOR AND ANTICOAGULANT COMPRISING THEREOF |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US7192968B2 (en) |
| EP (2) | EP1270557B1 (en) |
| JP (2) | JP4495896B2 (en) |
| KR (1) | KR100769592B1 (en) |
| CN (1) | CN1293057C (en) |
| AR (1) | AR027998A1 (en) |
| AU (2) | AU2001246835B2 (en) |
| BR (1) | BR0110052A (en) |
| CA (1) | CA2405144A1 (en) |
| ES (2) | ES2389021T3 (en) |
| IL (1) | IL151710A0 (en) |
| MX (1) | MXPA02009805A (en) |
| NO (1) | NO324003B1 (en) |
| RU (1) | RU2268259C2 (en) |
| TW (2) | TWI290136B (en) |
| WO (1) | WO2001074774A1 (en) |
| ZA (1) | ZA200207331B (en) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI290136B (en) * | 2000-04-05 | 2007-11-21 | Daiichi Seiyaku Co | Ethylenediamine derivatives |
| WO2002072548A2 (en) | 2001-03-09 | 2002-09-19 | Ortho-Mcneil Pharmaceutical, Inc. | Heterocyclic compounds and their use as histamine h4 ligands. |
| GB0112834D0 (en) | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
| CN1826333B (en) * | 2001-06-20 | 2012-12-26 | 第一三共株式会社 | Diamine derivatives |
| WO2003000657A1 (en) * | 2001-06-20 | 2003-01-03 | Daiichi Pharmaceutical Co., Ltd. | Diamine derivatives |
| AU2002328596B2 (en) * | 2001-08-09 | 2007-09-20 | Daiichi Pharmaceutical Co., Ltd. | Diamine derivatives |
| AR037097A1 (en) | 2001-10-05 | 2004-10-20 | Novartis Ag | ACILSULFONAMID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND THE USE OF SUCH COMPOUNDS FOR THE PREPARATION OF A MEDICINAL PRODUCT |
| WO2008011131A2 (en) * | 2006-07-21 | 2008-01-24 | Takeda Pharmaceutical Company Limited | Amide compounds |
| CA2478232C (en) * | 2002-04-11 | 2011-06-14 | Boehringer Ingelheim Pharmaceuticals, Inc. | Heterocyclic amide derivatives as cytokine inhibitors |
| NZ538401A (en) | 2002-09-06 | 2008-03-28 | Janssen Pharmaceutica Nv | (1H-benzoimidazol-2-yl)-(piperazinyl)-methanone derivatives and related compounds as histamine H4-receptor antagonists for the treatment of inflammatory and allergic disorders |
| PE20040804A1 (en) * | 2002-12-19 | 2004-12-31 | Boehringer Ingelheim Pharma | CARBOXAMID DERIVATIVES AS INHIBITORS OF THE Xa FACTOR |
| EP1577302A4 (en) * | 2002-12-24 | 2010-09-01 | Daiichi Seiyaku Co | Novel ethylenediamine derivatives |
| KR20050110612A (en) * | 2002-12-25 | 2005-11-23 | 다이이찌 세이야꾸 가부시기가이샤 | Diamine derivatives |
| CN1751025B (en) * | 2002-12-25 | 2010-05-12 | 第一制药株式会社 | Diamine derivatives |
| JP4630267B2 (en) * | 2002-12-25 | 2011-02-09 | 第一三共株式会社 | Diamine derivatives |
| US7205318B2 (en) * | 2003-03-18 | 2007-04-17 | Bristol-Myers Squibb Company | Lactam-containing cyclic diamines and derivatives as a factor Xa inhibitors |
| US7230133B2 (en) | 2003-05-01 | 2007-06-12 | Bristol-Myers Squibb Company | Malonamides and malonamide derivatives as modulators of chemokine receptor activity |
| US7291615B2 (en) | 2003-05-01 | 2007-11-06 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
| EP1670739A4 (en) * | 2003-10-08 | 2007-08-08 | Bristol Myers Squibb Co | Cyclic diamines and derivatives as factor xa inhibitors |
| CA2773066A1 (en) * | 2003-11-12 | 2005-05-26 | Daiichi Sankyo Company, Limited | Process for producing thiazole derivative |
| US7371743B2 (en) | 2004-02-28 | 2008-05-13 | Boehringer Ingelheim International Gmbh | Carboxylic acid amides, the preparation thereof and their use as medicaments |
| BRPI0615775B1 (en) | 2005-09-16 | 2021-08-10 | Daiichi Sankyo Company, Limited | PROCESSES FOR THE PRODUCTION OF OPTICALLY ACTIVE DIAMIDE DERIVED COMPOUNDS |
| JP5187901B2 (en) | 2006-08-30 | 2013-04-24 | 塩野義製薬株式会社 | Hydrazine amide derivatives |
| CN104324015B (en) | 2007-03-29 | 2018-08-28 | 第一三共株式会社 | Pharmaceutical composition |
| TW200909437A (en) * | 2007-06-21 | 2009-03-01 | Daiichi Sankyo Co Ltd | Process for the preparation of diamine-derivatives |
| US20100015306A1 (en) * | 2008-07-15 | 2010-01-21 | Pepsico, Inc. | Method for Preparing a Low Viscosity Whole Grain Flour Slurry |
| CA2747427C (en) | 2008-12-17 | 2015-10-13 | Daiichi Sankyo Company, Limited | Method for producing diamine derivative |
| JPWO2010082531A1 (en) | 2009-01-13 | 2012-07-05 | 第一三共株式会社 | Activated blood coagulation factor inhibitor |
| US20100178400A1 (en) * | 2009-01-13 | 2010-07-15 | Pepsico, Inc. | Method of Preparing a Whole Grain Beverage |
| CN102348688B (en) | 2009-03-10 | 2014-07-09 | 第一三共株式会社 | Process for producing diamine derivative |
| EP2407450B1 (en) | 2009-03-13 | 2015-04-22 | Daiichi Sankyo Company, Limited | Method for producing optically active diamine derivative |
| SG176934A1 (en) | 2009-06-18 | 2012-01-30 | Daiichi Sankyo Co Ltd | Pharmaceutical composition having improved solubility |
| ES2560955T3 (en) | 2010-03-19 | 2016-02-23 | Daiichi Sankyo Company, Limited | Diamine derivative crystal and its production process |
| EP2548556B1 (en) | 2010-03-19 | 2016-08-10 | Daiichi Sankyo Company, Limited | Method for improving dissolvability of anticoagulant |
| KR101795096B1 (en) | 2010-07-02 | 2017-12-01 | 다이이찌 산쿄 가부시키가이샤 | Process for preparation of optically active diamine derivative salt |
| JPWO2013022059A1 (en) | 2011-08-10 | 2015-03-05 | 第一三共株式会社 | Pharmaceutical composition containing diamine derivative |
| CN102516249A (en) * | 2011-12-08 | 2012-06-27 | 成都苑东药业有限公司 | Anticoagulant diamine derivative |
| CN102731316B (en) * | 2012-05-21 | 2014-04-16 | 南通市华峰化工有限责任公司 | Production method for 1,2-N,N'dimethylcyclohexanediamine |
| CA2896338A1 (en) | 2013-03-29 | 2014-10-02 | Daiichi Sankyo Company, Limited | Method for producing (1s,4s,5s)-4-bromo-6-oxabicyclo[3.2.1]octan-7-one |
| TWI602803B (en) | 2013-03-29 | 2017-10-21 | 第一三共股份有限公司 | Preparation method of optically active diamine compound |
| CA2940001C (en) * | 2014-02-18 | 2019-01-15 | Daiichi Sankyo Company, Limited | Method for producing inhibitor of activated blood coagulation factor x (fxa) |
| BR112016022785B8 (en) | 2014-04-04 | 2020-09-15 | Iomet Pharma Ltd | tryptophan-2,3-dioxigenase (tdo) and / or indoleamine-2,3-dioxigenase (acid) inhibitor compound, pharmaceutical composition, and use of tryptophan-2,3-dioxigenase (tdo) inhibitor and / or indoleamine-2,3dioxigenase (acid) or a pharmaceutically acceptable salt thereof for the manufacture of a medicinal product |
| CN104163802B (en) * | 2014-07-08 | 2016-04-27 | 浙江大学 | The preparation method of thiazolamine-4-ethyl formate |
| CA2960275A1 (en) * | 2014-09-10 | 2016-03-17 | Epizyme, Inc. | Smyd inhibitors |
| US10858319B2 (en) | 2016-10-03 | 2020-12-08 | Iomet Pharma Ltd. | Indole derivatives for use in medicine |
| CN108689878B (en) * | 2017-04-10 | 2023-05-09 | 浙江九洲药业股份有限公司 | Preparation method of optically active diamino derivatives |
| CN108840816A (en) * | 2018-05-25 | 2018-11-20 | 郑州依米花手性药物研究有限公司 | Acid imide midbody compound and its preparation method and application |
Family Cites Families (97)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4707440A (en) | 1984-01-30 | 1987-11-17 | Enzo Biochem, Inc. | Nucleic acid hybridization assay and detectable molecules useful in such assay |
| IL100576A (en) | 1991-01-18 | 1995-11-27 | Eli Lilley And Company | Cephalosporin antibiotics |
| AU2913292A (en) | 1991-11-14 | 1993-06-15 | Bernard Derek Frutin | A pressurised container |
| US5264457A (en) | 1992-02-14 | 1993-11-23 | G. D. Searle & Co. | Phenyl amidines sulfonamides useful as platelet aggregation inhibitors |
| JP2875930B2 (en) * | 1992-12-02 | 1999-03-31 | 富士写真フイルム株式会社 | Optical rotation film and liquid crystal display device using the same |
| US5430150A (en) * | 1992-12-16 | 1995-07-04 | American Cyanamid Company | Retroviral protease inhibitors |
| CA2157412A1 (en) | 1993-03-03 | 1994-09-15 | Julia Marie Heerding | Balanoids |
| DK0641770T3 (en) | 1993-03-17 | 1998-06-02 | Meiji Seika Co | New compounds with platelet aggregation inhibitory activity |
| US5707994A (en) * | 1993-10-19 | 1998-01-13 | Sumitomo Pharmaceuticals Company, Limited | 2,3-diaminopropionic acid derivative |
| TW270114B (en) | 1993-10-22 | 1996-02-11 | Hoffmann La Roche | |
| CA2174838A1 (en) * | 1993-11-24 | 1995-06-01 | John Wityak | Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
| US5849736A (en) * | 1993-11-24 | 1998-12-15 | The Dupont Merck Pharmaceutical Company | Isoxazoline and isoxazole fibrinogen receptor antagonists |
| US5563158A (en) * | 1993-12-28 | 1996-10-08 | The Dupont Merck Pharmaceutical Company | Aromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonists |
| WO1995032965A1 (en) | 1994-06-01 | 1995-12-07 | Yamanouchi Pharmaceutical Co. Ltd. | Oxadiazole derivative and medicinal composition thereof |
| IL115420A0 (en) | 1994-09-26 | 1995-12-31 | Zeneca Ltd | Aminoheterocyclic derivatives |
| US5719144A (en) * | 1995-02-22 | 1998-02-17 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| ATE242231T1 (en) | 1995-04-07 | 2003-06-15 | Schering Corp | CARBONYL-PIPERAZNYL AND PIPERIDINYL DERIVATIVES FOR INHIBITING FARNESYL PROTEIN TRANSFERASE |
| DE19516954C1 (en) | 1995-05-12 | 1996-12-19 | Max Planck Gesellschaft | Method for the spatially resolved immunohistochemical detection of steroid receptors |
| ZA963391B (en) * | 1995-05-24 | 1997-10-29 | Du Pont Merck Pharma | Isoxazoline fibrinogen receptor antagonists. |
| IL118007A0 (en) | 1995-05-24 | 1996-08-04 | Du Pont Merck Pharma | Isoxazoline compounds pharmaceutical compositions containing them and their use |
| US5726126A (en) | 1995-06-02 | 1998-03-10 | American Cyanamid Company | 1-(3-heterocyclyphenyl)-S-triazine-2,6,6-oxo or thiotrione herbicidal agents |
| US5741819A (en) | 1995-06-07 | 1998-04-21 | 3-Dimensional Pharmaceuticals, Inc. | Arylsulfonylaminobenzene derivatives and the use thereof as factor Xa inhibitors |
| GB9516709D0 (en) | 1995-08-15 | 1995-10-18 | Zeneca Ltd | Medicament |
| US5852045A (en) * | 1995-10-19 | 1998-12-22 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| JPH11513686A (en) * | 1995-10-19 | 1999-11-24 | メルク エンド カンパニー インコーポレーテッド | Fibrinogen receptor antagonist |
| US6274715B1 (en) | 1995-11-08 | 2001-08-14 | Abbott Laboratories | Tricyclic erythromycin derivatives |
| GB9602294D0 (en) | 1996-02-05 | 1996-04-03 | Zeneca Ltd | Heterocyclic compounds |
| AU2733997A (en) | 1996-04-17 | 1997-11-07 | Du Pont Pharmaceuticals Company | N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-one derivatives as factor xa inhibitors |
| US5668159A (en) | 1996-05-08 | 1997-09-16 | The Dupont Merck Pharmaceutical Company | 1,3,4-thiadiazoles and 1,3,4-oxadiazoles as IIb/IIIa antagonists |
| WO1997048395A1 (en) * | 1996-06-19 | 1997-12-24 | Du Pont Pharmaceuticals Company | Iontophoretic delivery of integrin inhibitors |
| WO1998006720A1 (en) | 1996-08-09 | 1998-02-19 | Eisai Co., Ltd. | Benzopiperidine derivatives |
| JP2000516602A (en) | 1996-08-14 | 2000-12-12 | ゼネカ・リミテッド | Substituted pyrimidine derivatives and their use as medicaments |
| US6004955A (en) * | 1996-08-15 | 1999-12-21 | Dupont Pharmaceuticals Company | Cyclic carbamates and isoxazolidines as IIb/IIIa antagonists |
| JP2000516230A (en) | 1996-08-15 | 2000-12-05 | デュポン ファーマシューティカルズ カンパニー | Cyclic carbamates and isoxazolidines as IIB / IIIA antagonists |
| US5871762A (en) * | 1996-10-07 | 1999-02-16 | The Procter & Gamble Company | Cosmetic applicators which contain stable oil-in-water emulsions |
| UA56197C2 (en) | 1996-11-08 | 2003-05-15 | Зенека Лімітед | Heterocyclic derivatives |
| EP0966460A1 (en) | 1997-02-13 | 1999-12-29 | Zeneca Limited | Heterocyclic compounds useful as oxido-squalene cyclase inhibitors |
| IT1291823B1 (en) * | 1997-04-08 | 1999-01-21 | Menarini Ricerche Spa | PSEUDO-PEPTIDE COMPOUNDS, THEIR PREPARATION AND USE IN PHARMACEUTICAL FORMULATIONS |
| AR012443A1 (en) | 1997-04-16 | 2000-10-18 | Uriach & Cia Sa J | NEW CARBOXAMIDS AS INHIBITORS OF THE PLATELET AGGREGATION, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USE OF THE SAME IN THE MANUFACTURE OF MEDICINES |
| ATE334975T1 (en) | 1997-05-30 | 2006-08-15 | Takeda Pharmaceutical | SULFONAMIDE DERIVATIVES, THEIR PRODUCTION AND USE |
| US6207679B1 (en) | 1997-06-19 | 2001-03-27 | Sepracor, Inc. | Antimicrobial agents uses and compositions related thereto |
| EP0991623A2 (en) * | 1997-06-19 | 2000-04-12 | Sepracor, Inc. | Quinoline-indole antimicrobial agents, uses and compositions related thereto |
| WO1999000127A1 (en) | 1997-06-26 | 1999-01-07 | Eli Lilly And Company | Antithrombotic agents |
| CA2295153A1 (en) | 1997-06-26 | 1999-01-07 | Gerald Floyd Smith | Antithrombotic agents |
| AU8270898A (en) | 1997-06-26 | 1999-01-19 | Eli Lilly And Company | Antithrombotic agents |
| GB9715895D0 (en) | 1997-07-29 | 1997-10-01 | Zeneca Ltd | Heterocyclic compounds |
| GB9715894D0 (en) | 1997-07-29 | 1997-10-01 | Zeneca Ltd | Heterocyclic derivatives |
| ID23991A (en) | 1997-09-30 | 2000-06-14 | Daiichi Seiyaku Co | SULFONIL DRIVINGS |
| AR013693A1 (en) | 1997-10-23 | 2001-01-10 | Uriach & Cia Sa J | NEW PIPERIDINES AND PIPERAZINAS AS INHIBITORS OF THE PLAQUETARY AGREGATION |
| EP0937723A1 (en) | 1998-02-18 | 1999-08-25 | Roche Diagnostics GmbH | Novel sulfonamides, process for their preparation and medicaments containing them |
| EP0937711A1 (en) | 1998-02-18 | 1999-08-25 | Roche Diagnostics GmbH | Thiobenzamides, process for their preparation and medicaments containing them |
| EP1061934A1 (en) * | 1998-03-09 | 2000-12-27 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| TR200003200T2 (en) | 1998-05-02 | 2001-02-21 | Astrazeneca Ab | Heterocyclic derivatives that prevent factor XA. |
| GB9809350D0 (en) | 1998-05-02 | 1998-07-01 | Zeneca Ltd | Novel salt |
| GB9809349D0 (en) | 1998-05-02 | 1998-07-01 | Zeneca Ltd | Heterocyclic derivatives |
| JP2000086659A (en) * | 1998-07-14 | 2000-03-28 | Takeda Chem Ind Ltd | Octahydropyrido[1,2-alpha]pyrazine derivative |
| FR2781221B1 (en) * | 1998-07-17 | 2000-10-13 | Lafon Labor | ALPHA SUBSTITUTED PIPERAZINONES |
| US6303625B1 (en) | 1998-07-27 | 2001-10-16 | Ortho-Mcneil Pharmaceutical, Inc. | Triazolopyridines for the treatment of thrombosis disorders |
| JP2000119253A (en) | 1998-08-11 | 2000-04-25 | Dai Ichi Seiyaku Co Ltd | Novel sulfonyl derivative |
| EP1104754A1 (en) | 1998-08-11 | 2001-06-06 | Daiichi Pharmaceutical Co., Ltd. | Novel sulfonyl derivatives |
| DE69907962T2 (en) * | 1998-12-14 | 2004-05-19 | Vertex Pharmaceuticals (San Diego) Llc, San Diego | OPTICAL MOLECULAR SENSORS FOR CYTOCHROME P-450 ACTIVITY |
| WO2000039117A1 (en) | 1998-12-23 | 2000-07-06 | Eli Lilly And Company | HETEROROAROMATIC AMIDES AS INHIBITOR OF FACTOR Xa |
| EP1140903B1 (en) | 1998-12-23 | 2004-08-04 | Eli Lilly And Company | Aromatic amides |
| JP2004522689A (en) | 1998-12-23 | 2004-07-29 | イーライ・リリー・アンド・カンパニー | Antithrombotic amides |
| DE69915687T2 (en) | 1998-12-24 | 2005-02-10 | Eli Lilly And Co., Indianapolis | HETEROCYCLIC AMIDS AS INHIBITORS OF FACTOR XA |
| GB9902989D0 (en) | 1999-02-11 | 1999-03-31 | Zeneca Ltd | Heterocyclic derivatives |
| AU766089B2 (en) * | 1999-03-11 | 2003-10-09 | Du Pont Pharmaceuticals Company | Treatment of thrombosis by combined use of a factor Xa inhibitor and aspirin, tissue plasminogen activator (TPA), a GPIIb/IIIa antagonist, low molecular weight heparin or heparin |
| AU2241400A (en) * | 1999-04-06 | 2000-10-12 | Yamanouchi Pharmaceutical Co., Ltd. | Novel thiazolobenzoimidazole derivative |
| JP4390024B2 (en) | 1999-04-23 | 2009-12-24 | アステラス製薬株式会社 | Novel diazepane derivatives or salts thereof |
| AU5284000A (en) | 1999-05-24 | 2000-12-12 | Cor Therapeutics, Inc. | Inhibitors of factor xa |
| AU5414000A (en) | 1999-06-14 | 2001-01-02 | Eli Lilly And Company | Compounds |
| GB9914342D0 (en) | 1999-06-19 | 1999-08-18 | Zeneca Ltd | Compound |
| JP2001011071A (en) * | 1999-06-25 | 2001-01-16 | Mochida Pharmaceut Co Ltd | Aminoalkyl sulfonamide derivatives |
| GB9917344D0 (en) | 1999-07-24 | 1999-09-22 | Zeneca Ltd | Novel salt |
| BR0013926A (en) | 1999-09-13 | 2002-07-23 | Dimensional Pharm Inc | Azacycloalkanone serine protease inhibitors |
| BR0014078A (en) | 1999-09-17 | 2002-12-31 | Millennium Pharm Inc | Xa factor inhibitors |
| JP4744050B2 (en) | 1999-09-17 | 2011-08-10 | ミレニアム・ファーマシューティカルズ・インコーポレイテッド | Benzamide and related factor Xa inhibitors |
| WO2001027090A1 (en) * | 1999-10-08 | 2001-04-19 | Meiji Seika Kaisha, Ltd. | m-SUBSTITUTED BENZOIC ACID DERIVATIVES EXHIBITING INTEGRINαvβ3 ANTAGONISM |
| AU1770001A (en) | 1999-11-24 | 2001-06-04 | Cor Therapeutics, Inc. | Beta-amino acid-, aspartic acid- and diaminopropionic-based inhibitors of factorxa |
| US6376515B2 (en) | 2000-02-29 | 2002-04-23 | Cor Therapeutics, Inc. | Benzamides and related inhibitors of factor Xa |
| TWI290136B (en) * | 2000-04-05 | 2007-11-21 | Daiichi Seiyaku Co | Ethylenediamine derivatives |
| US6586418B2 (en) | 2000-06-29 | 2003-07-01 | Bristol-Myers Squibb Company | Thrombin or factor Xa inhibitors |
| AU2001294824A1 (en) | 2000-09-29 | 2002-04-08 | Millennium Pharmaceuticals, Inc. | Piperazine based inhibitors of factor xa |
| WO2002026712A2 (en) | 2000-09-29 | 2002-04-04 | Millennium Pharmaceuticals, Inc. | Quaternary amines and related inhibitors of factor xa |
| US20040072860A1 (en) | 2000-09-29 | 2004-04-15 | Bing-Yan Zhu | Piperazin-2-one amides as inhibitors of factor xa |
| US6710058B2 (en) | 2000-11-06 | 2004-03-23 | Bristol-Myers Squibb Pharma Company | Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors |
| PT1336605E (en) | 2000-11-22 | 2006-06-30 | Astellas Pharma Inc | SUBSTITUTED PHENOL DERIVATIVES OR ITS SALTS AS COAGULATION FACTOR X INHIBITORS |
| CA2432369A1 (en) | 2000-12-20 | 2002-08-08 | Bristol-Myers Squibb Pharma Company | Cyclic derivatives as modulators of chemokine receptor activity |
| WO2002079145A1 (en) | 2001-03-30 | 2002-10-10 | Millennium Pharmaceuticals, Inc. | BENZAMIDE INHIBITORS OF FACTOR Xa |
| CN1826333B (en) | 2001-06-20 | 2012-12-26 | 第一三共株式会社 | Diamine derivatives |
| WO2003000657A1 (en) * | 2001-06-20 | 2003-01-03 | Daiichi Pharmaceutical Co., Ltd. | Diamine derivatives |
| AU2002328596B2 (en) | 2001-08-09 | 2007-09-20 | Daiichi Pharmaceutical Co., Ltd. | Diamine derivatives |
| CN101357914A (en) | 2001-09-21 | 2009-02-04 | 百时美施贵宝公司 | Lactam-containing compounds and their derivatives as inhibitors of factor Xa |
| US7030141B2 (en) | 2001-11-29 | 2006-04-18 | Christopher Franklin Bigge | Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| AU2002350217A1 (en) | 2001-12-04 | 2003-06-17 | Bristol-Myers Squibb Company | Glycinamides as factor xa inhibitors |
| EP1577302A4 (en) | 2002-12-24 | 2010-09-01 | Daiichi Seiyaku Co | Novel ethylenediamine derivatives |
| KR20050110612A (en) | 2002-12-25 | 2005-11-23 | 다이이찌 세이야꾸 가부시기가이샤 | Diamine derivatives |
-
2001
- 2001-04-03 TW TW090107988A patent/TWI290136B/en not_active IP Right Cessation
- 2001-04-03 TW TW096119881A patent/TWI288745B/en not_active IP Right Cessation
- 2001-04-04 AR ARP010101613A patent/AR027998A1/en not_active Application Discontinuation
- 2001-04-05 WO PCT/JP2001/002945 patent/WO2001074774A1/en not_active Ceased
- 2001-04-05 AU AU2001246835A patent/AU2001246835B2/en not_active Ceased
- 2001-04-05 ES ES01919784T patent/ES2389021T3/en not_active Expired - Lifetime
- 2001-04-05 KR KR1020027013005A patent/KR100769592B1/en not_active Expired - Fee Related
- 2001-04-05 US US10/240,725 patent/US7192968B2/en not_active Expired - Fee Related
- 2001-04-05 AU AU4683501A patent/AU4683501A/en active Pending
- 2001-04-05 BR BR0110052-1A patent/BR0110052A/en not_active IP Right Cessation
- 2001-04-05 IL IL15171001A patent/IL151710A0/en unknown
- 2001-04-05 ES ES11009091T patent/ES2417860T3/en not_active Expired - Lifetime
- 2001-04-05 RU RU2002129354/04A patent/RU2268259C2/en not_active IP Right Cessation
- 2001-04-05 MX MXPA02009805A patent/MXPA02009805A/en active IP Right Grant
- 2001-04-05 EP EP01919784A patent/EP1270557B1/en not_active Expired - Lifetime
- 2001-04-05 JP JP2001572469A patent/JP4495896B2/en not_active Expired - Fee Related
- 2001-04-05 CA CA002405144A patent/CA2405144A1/en not_active Abandoned
- 2001-04-05 CN CNB018086187A patent/CN1293057C/en not_active Expired - Fee Related
- 2001-04-05 EP EP11009091.7A patent/EP2431370B1/en not_active Expired - Lifetime
-
2002
- 2002-09-12 ZA ZA200207331A patent/ZA200207331B/en unknown
- 2002-10-03 NO NO20024766A patent/NO324003B1/en unknown
-
2005
- 2005-09-02 US US11/217,837 patent/US20060004009A1/en not_active Abandoned
-
2009
- 2009-05-13 US US12/465,329 patent/US7935824B2/en not_active Expired - Fee Related
-
2010
- 2010-02-04 JP JP2010022631A patent/JP5113200B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2002129354A (en) | Ethylenediamine derivatives | |
| JP2004509114A5 (en) | ||
| RU2004101279A (en) | DIAMINE DERIVATIVES | |
| EP1379507B1 (en) | HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS | |
| RU99128053A (en) | NEW CYCLIC COMPOUNDS OF DIAMINE AND THEIR MEDICINES CONTAINING THEM | |
| RU2005123394A (en) | DIAMINE DERIVATIVES | |
| RU2000102359A (en) | PHARMACEUTICAL COMPOSITION HAVING AN IMPROVED ANTI-CANCER ACTION AND / OR REDUCED SIDE EFFECTS CONTAINING ANTI-CANCER AGENT AND HYDROXAMIC DERIVATIVE DERIVATIVE | |
| CA2405521A1 (en) | Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties | |
| JP2012503655A5 (en) | ||
| JP2005501120A5 (en) | ||
| RU2001132635A (en) | Piperidine derivatives useful as cc R5 antagonists | |
| JP2006515858A5 (en) | ||
| RU2004109812A (en) | 2-cyano-4-aminopyrimidine cysteine protease inhibitors with an inhibitory effect on cathepsin K for the treatment of inflammatory and other diseases | |
| RU2003129638A (en) | NEW COMPOUNDS | |
| CA2422367A1 (en) | Pyrazole compounds useful as protein kinase inhibitors | |
| JP2004509118A5 (en) | ||
| RU2003113205A (en) | AMINOPYRIDINYL-, AMINOGUANIDINYL- AND ALCOXYGUANIDINYL-SUBSTITUTED PHENYLACETAMIDES AND THEIR APPLICATION AS PROTEAZ INHIBITORS | |
| BE899132A (en) | THIAZOLIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| JP2008517923A5 (en) | ||
| KR950014067A (en) | Arylamide derivatives | |
| RU2004119963A (en) | HIV INTEGRAS INHIBITORS | |
| RU2220140C2 (en) | Derivative of cyclic amides, pharmaceutical composition and medicinal agent comprising thereof and method for treatment of allergic disease | |
| JP2005515976A5 (en) | ||
| RU2005123390A (en) | NEW Ethylenediamine Derivatives | |
| RU2003110575A (en) | PYRAZOLE DERIVATIVES USED AS RETEINKINASE INHIBITORS |